1. Home
  2. ZSTK vs ALLR Comparison

ZSTK vs ALLR Comparison

Compare ZSTK & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZeroStack Corp. Common Stock

ZSTK

ZeroStack Corp. Common Stock

N/A

Current Price

$5.53

Market Cap

19.0M

Sector

Health Care

ML Signal

N/A

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.45

Market Cap

21.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZSTK
ALLR
Founded
2019
2004
Country
Canada
United States
Employees
N/A
8
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
21.5M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
ZSTK
ALLR
Price
$5.53
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
16.0K
64.6K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,676,000.00
$320,000.00
Revenue This Year
$15.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.77
52 Week High
$11.00
$2.35

Technical Indicators

Market Signals
Indicator
ZSTK
ALLR
Relative Strength Index (RSI) 82.33 62.51
Support Level $4.76 $1.21
Resistance Level $9.65 $1.55
Average True Range (ATR) 0.96 0.10
MACD 0.34 0.01
Stochastic Oscillator 37.28 72.22

Price Performance

Historical Comparison
ZSTK
ALLR

About ZSTK ZeroStack Corp. Common Stock

ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: